Trending...
- Donna L. Quesinberry, President of DonnaInk Publications, Unveils New Article on Author Monetization
- Strategic Expansion with 3 New Alliances — Jefferson Beach Yacht Sales, CFR YS & flyExclusive Incentive Partnership: Off The Hook YS: (N Y S E: OTH)
- Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch
Through a new partnership, Acmeware will provide a FHIR-enabled integration layer that allows Avo to access MEDITECH clinical data in real time at the point of care.
MEDFIELD, Mass. - Marylandian -- Acmeware, a MEDITECH Alliance Partner, announced a partnership with Avo (AvoMD), an AI platform for clinical copilots and a fellow MEDITECH Alliance Partner. Together, the organizations are enabling MEDITECH customers to seamlessly push and pull data between MEDITECH and Avo's AI-powered clinical tools. As part of this partnership, Acmeware will serve as a seamless data integration layer for Avo's AI suite within MEDITECH environments, delivering a standards-based API using the HL7® FHIR® data format.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on Marylandian
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on Marylandian
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on Marylandian
- Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
- Costa Oil Named Primary Sponsor of Carson Ware for the United Rentals 300 at Daytona International Speedway
- HBMHCW Expande Infraestructura de Cumplimiento para Argentina mientras América Latina Supera $1.5 Billones en Volumen Cripto
- Norisia Launches AI Formulated Luxury Multivitamin to Transform Daily Wellness in the UK
- Tuck & Patti Bring Over Three Decades of Music to the Weinberg Center
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on Marylandian
- Jacob Emrani's Annual "Supper Bowl" Expected To Donate Thousands Of Meals
- NASA / Glenn Research Center Collaboration to Help Meet Rising Demand for Space Energy Beaming Tech / CIGS PV Modules from Ascent Solar: NAS DAQ: ASTI
- Maryland: Department Extends Deadline for Farmers to File Annual Implementation Reports (AIRs)
- When Interpretation Becomes Conversation: Rethinking Engagement in the Museum Age
- Half of Finnish Online Gambling Expenditure Now Flows to Offshore Instant Casinos as License Applications Open March 1, 2026
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Media Contact
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Source: Acmeware, Inc
0 Comments
Latest on Marylandian
- Luxury Lake-View Home Launches in Kissimmee's Bellalago community, Offering Privacy, Space, and Florida Resort-Style Living
- Sleep Basil Launches Revamped Diamond Mattress Collection Page, Highlighting Performance, Craftsmanship, and Personalized Comfort
- Sleep Basil Curates a Clearer Brooklyn Bedding Experience for Performance-Minded Denver Sleepers
- JiT Home Buyers Expands Maryland Services to Help Baltimore Homeowners Sell Houses Fast
- Nevada Man Launches Nationwide Animal Abuse Registry
- V.HIGGZ All-Star Birthday Jam Brings Music, Star Power, and Celebration
- Star-powered Kappa Takeover Weekend Returns to the DMV June 18- 21, 2026, Hosted By Comedian Joe Clair W/ Dj Quick Silva (the Party Kingpin)
- Scoop Social Co. Wins The Knot and WeddingWire Awards as Brand Expands Nationwide
- Denise Murphy Lenci Promoted to Century Fasteners Corp. – General Manager, Northeast Sales
- TiNY Puts Real Pets on the Payroll for New PetArmor Campaign
- P‑Wave Classics Launches Definitive New Edition of Hannah Webster Foster's The Coquette
- Strategic Expansion with 3 New Alliances — Jefferson Beach Yacht Sales, CFR YS & flyExclusive Incentive Partnership: Off The Hook YS: (N Y S E: OTH)
- Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch
- Strategic Business Optimization Launches New Research & Insights Services
- purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
- CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
- Crossroads4Hope Kicks Off Its 25th Year of Caring with the Launch of Free Breast and Colorectal Cancer Resources for Patients and Families Nationwide
- OpenSSL Corporation Advisory Committees' Elections 2026: Voting Now Open
- dpInk Ltd Liability Company Expands Service Portfolio Across Production, Editorial, and Federal Stra
- Donna L. Quesinberry, President of DonnaInk Publications, Unveils New Article on Author Monetization
